Literature DB >> 26111588

Human Immunodeficiency Virus Type 1 Cellular Entry and Exit in the T Lymphocytic and Monocytic Compartments: Mechanisms and Target Opportunities During Viral Disease.

Benjamas Aiamkitsumrit1, Neil T Sullivan1, Michael R Nonnemacher1, Vanessa Pirrone1, Brian Wigdahl2.   

Abstract

During the course of human immunodeficiency virus type 1 infection, a number of cell types throughout the body are infected, with the majority of cells representing CD4+ T cells and cells of the monocyte-macrophage lineage. Both types of cells express, to varying levels, the primary receptor molecule, CD4, as well as one or both of the coreceptors, CXCR4 and CCR5. Viral tropism is determined by both the coreceptor utilized for entry and the cell type infected. Although a single virus may have the capacity to infect both a CD4+ T cell and a cell of the monocyte-macrophage lineage, the mechanisms involved in both the entry of the virus into the cell and the viral egress from the cell during budding and viral release differ depending on the cell type. These host-virus interactions and processes can result in the differential targeting of different cell types by selected viral quasispecies and the overall amount of infectious virus released into the extracellular environment or by direct cell-to-cell spread of viral infectivity. This review covers the major steps of virus entry and egress with emphasis on the parts of the replication process that lead to differences in how the virus enters, replicates, and buds from different cellular compartments, such as CD4+ T cells and cells of the monocyte-macrophage lineage.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Assembly; CD4(+) T cells; Entry; HIV-1; Monocytes/macrophages; Release; Tropism

Mesh:

Year:  2015        PMID: 26111588     DOI: 10.1016/bs.aivir.2015.04.001

Source DB:  PubMed          Journal:  Adv Virus Res        ISSN: 0065-3527            Impact factor:   9.937


  5 in total

Review 1.  Neuroimmunology of CNS HIV Infection: A Narrative Review.

Authors:  Ana-Claire Meyer; Alfred Kongnyu Njamnshi; Magnus Gisslen; Richard W Price
Journal:  Front Neurol       Date:  2022-06-14       Impact factor: 4.086

2.  PLGA-PEG Nanoparticles Coated with Anti-CD45RO and Loaded with HDAC Plus Protease Inhibitors Activate Latent HIV and Inhibit Viral Spread.

Authors:  Xiaolong Tang; Yong Liang; Xinkuang Liu; Shuping Zhou; Liang Liu; Fujina Zhang; Chunmei Xie; Shuyu Cai; Jia Wei; Yongqiang Zhu; Wei Hou
Journal:  Nanoscale Res Lett       Date:  2015-10-22       Impact factor: 4.703

3.  Highly Efficient Autologous HIV-1 Isolation by Coculturing Macrophage With Enriched CD4+ T Cells From HIV-1 Patients.

Authors:  Cristina Xufré; Tanía González; Lorna Leal; Charles M Trubey; Jeffrey D Lifson; José María Gatell; José Alcamí; Núria Climent; Felipe García; Sonsoles Sánchez-Palomino
Journal:  Front Virol       Date:  2022-04-07

4.  HIV-1 Genetic Variation Resulting in the Development of New Quasispecies Continues to Be Encountered in the Peripheral Blood of Well-Suppressed Patients.

Authors:  Will Dampier; Michael R Nonnemacher; Joshua Mell; Joshua Earl; Garth D Ehrlich; Vanessa Pirrone; Benjamas Aiamkitsumrit; Wen Zhong; Katherine Kercher; Shendra Passic; Jean W Williams; Jeffrey M Jacobson; Brian Wigdahl
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

Review 5.  COVID-19 and the kidney: what we think we know so far and what we don't.

Authors:  Samira S Farouk; Enrico Fiaccadori; Paolo Cravedi; Kirk N Campbell
Journal:  J Nephrol       Date:  2020-07-20       Impact factor: 3.902

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.